The House moves on antitrust and an infrastructure deal seems to have been reached. Plus much, much, more in tech policy news.
Should the FDA make aging a disease?
Should the FDA make aging a disease?
Should the FDA make aging a disease?
The House moves on antitrust and an infrastructure deal seems to have been reached. Plus much, much, more in tech policy news.